Sökning: onr:"swepub:oai:DiVA.org:uu-13245" >
Heterogeneous activ...
Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis
-
- Mahteme, Haile (författare)
- Uppsala universitet,Kolorektalkirurgi
-
- von Heideman, Anne (författare)
- Uppsala universitet,Enheten för onkologi
-
- Grundmark, Birgitta (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper,Cancer Pharmacology and Informatics/Rolf Larsson
-
visa fler...
-
Tholander, B. (författare)
-
- Påhlman, Lars (författare)
- Uppsala universitet,Kolorektalkirurgi
-
- Glimelius, Bengt (författare)
- Karolinska Institutet,Uppsala universitet,Enheten för onkologi,GI
-
- Larsson, Rolf (författare)
- Uppsala universitet,Klinisk farmakologi,Clinical Pharmacology and Informatics
-
- Graf, Wilhelm (författare)
- Uppsala universitet,Kolorektalkirurgi
-
- Nygren, Peter (författare)
- Uppsala universitet,Enheten för onkologi,Nygren
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2008
- 2008
- Engelska.
-
Ingår i: European Journal of Surgical Oncology. - : Elsevier BV. - 0748-7983 .- 1532-2157. ; 34:5, s. 547-552
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- AIMS: To investigate if the pattern of cytotoxic drug sensitivity in vitro in patient samples of peritoneal carcinomatosis (PC) is supportive to the current standardized approach for drug selection for perioperative intraperitoneal chemotherapy (IPC). METHODS: The cytotoxic effect of cisplatin, oxaliplatin, irinotecan, 5-fluorouracil, mitomycin-C, doxorubicin and melphalan was investigated in vitro on tumour cells from 223 patient tumour samples of different PC origins. RESULTS: Considerable differences in cytotoxic drug sensitivity between tumour types of the PC entity and within each tumour type were observed. Cisplatin showed high cross-resistance with oxaliplatin but low cross-resistance with doxorubicin and irinotecan. No cross-resistance was found between irinotecan and doxorubicin. The dose-response relationships for melphalan and irinotecan in individual samples showed great variability. CONCLUSIONS: The activity in vitro of cytotoxic drugs commonly used in IPC for PC is very heterogeneous. Efforts for individualizing drug selection for PC patients undergoing IPC seem justified.
Nyckelord
- Peritoneal carcinomatosis
- Intraperitoneal chemotherapy
- Cytotoxic drug
- In vitro
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas